List of redirects

Jump to navigation Jump to search

Showing below up to 50 results in range #581 to #630.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. ACTHomaNeuroendocrine tumors
  2. ACTIVATEAcat Inhibition On The Progression Of Coronary Atherosclerosis
  3. ACTIVE AThe Atrial Fibrillation Clopidogrel Trial With Irbesartan For Prevention Of Vascular Events
  4. ACTIVE WACTIVE W Trial
  5. ACTIV in CHFAcute And Chronic Therapeutic Impact Of A Vasopressin 2 Antagonist (Tolvaptan) In Congestive Heart Failure
  6. ACUITY HORIZONSACUITY HORIZONS bleeding criteria
  7. ACUITY PCI: 30-day and 1-Year ResultsAcute Catheterization And Urgent Intervention Triage Strategy Trial - Pci Subgroup: 30-Day And 1-Year Results
  8. ACUITY Timing TrialAcute Catheterization And Urgent Intervention Triage Strategy Timing Trial
  9. ACUTEAssessment Of Cardioversion Using Transesophageal Echocardiography
  10. ACUTE IIAssessment Of Cardioversion Using Transesophageal Echocardiography
  11. ACY2 DeficiencyCanavan disease
  12. ACY2 deficiencyCanavan disease
  13. AChAcetylcholine
  14. ACh receptorAcetylcholine receptor
  15. ADAlzheimer's disease
  16. AD4PSEN2
  17. ADAMTS-13ADAMTS13
  18. ADAM metallopeptidase with thrombospondin type 1 motif, 10ADAMTS10
  19. ADAPTAlzheimer's Disease Anti-Inflammatory Prevention Trial
  20. ADCSAlzheimer's Disease Cooperative Study
  21. ADDAttention-deficit hyperactivity disorder
  22. ADD/ADHDAttention-deficit hyperactivity disorder
  23. ADEAdverse drug reaction
  24. ADEKsMultivitamin
  25. ADEMAcute disseminated encephalomyelitis
  26. ADEMEXAdequacy Of Peritoneal Dialysis In Mexico
  27. ADHAntidiuretic hormone
  28. ADHDAttention-deficit hyperactivity disorder
  29. ADHD predominantly hyperactive-impulsiveAttention-deficit hyperactivity disorder
  30. ADHFCongestive heart failure acute pharmacotherapy
  31. ADH inappropriateSyndrome of inappropriate antidiuretic hormone
  32. ADIOSAntiarrhythmic Drug Improve Outcome Study
  33. ADLActivities of daily living
  34. ADLSActivities of daily living
  35. ADLsActivities of daily living
  36. ADME-ToxADME
  37. ADMITArterial Disease Multiple Intervention Trial
  38. ADNFLEAutosomal dominant nocturnal frontal lobe epilepsy
  39. ADONISAspirin Dose Optimized In Noncardioembolic Ischemic Stroke
  40. ADOPTAtrial Dynamic Overdrive Pacing Trial
  41. ADOPT-AAtrial Dynamic Overdrive Pacing Trial-A
  42. ADPAdenosine diphosphate
  43. ADPKDPolycystic kidney disease
  44. ADP receptorPurinergic receptor
  45. ADP riboseAdenosine diphosphate ribose
  46. ADRAdverse drug reaction
  47. ADRA2AAlpha-2A adrenergic receptor
  48. ADRA2BAlpha-2B adrenergic receptor
  49. ADRA2CAlpha-2C adrenergic receptor
  50. ADVANCEA Randomized Comparison Of The Value Of Additional Stenting After Optimal Balloon Angioplasty For Long Coronary Lesions

View ( | ) (20 | 50 | 100 | 250 | 500)